Notices. Notice
296 words·~1 min read·
/register/2020/11/12/2020-25019·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2019-N-3065; FDA-2016-N-4620; FDA-2019-N-6063; FDA-2017-N-1066; FDA-2018-N-3065; FDA-2008-N-0424; and FDA-2019-N-5711] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Required Warnings for Cigarette Packages and Advertisements 0910-0877 04/30/2023 Medical Devices; Reports of Corrections and Removals 0910-0359 10/31/2023 Customer/Partner Service Surveys 0910-0360 10/31/2023 Annual Reporting for Custom Device Exemption 0910-0767 10/31/2023 Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act 0910-0800 10/31/2023 Postmarketing Safety Reporting for Combination Products 0910-0834 10/31/2023 Importation of Prescription Drugs 0910-0888 10/31/2023 Dated: November 5, 2020. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2020-25019 Filed 11-10-20; 8:45 am]
Connectionstraces to 1
Traces to 1 document